Comparative benefit-risk profile of induction and maintenance therapy with upadacitinib versus placebo in patients with moderately to severely active ulcerative colitis

被引：0

作者：

Blumenstein, I. ^{[1
]}

Xuan, S. ^{[2
]}

Panaccione, R. ^{[3
]}

Baert, F. ^{[4
]}

Barreiro-de Acosta, M. ^{[5
]}

Ye, B. D. ^{[6
,7
]}

Klaff, J. ^{[2
]}

Vladea, R. ^{[2
]}

Levy, G. ^{[2
]}

Holweg, C. T. J. ^{[2
]}

Gonzalez, Y. Sanchez ^{[2
]}

Dubinsky, M. C. ^{[8
]}

机构：

[1] Goethe Univ Clin, Frankfurt, Germany

[2] AbbVie Inc, N Chicago, IL USA

[3] Univ Calgary, Dept Gastroenterol & Hepatol, Calgary, AB, Canada

[4] AZ Delta, Dept Gastroenterol, Roeselare, Belgium

[5] Univ Hosp Santiago de Compostela, Inflammatory Bowel Dis Unit, Galicia, Spain

[6] Univ Ulsan, Asan Med Ctr, Coll Med, Dept Gastroenterol, Seoul, South Korea

[7] Univ Ulsan, Inflammatory Bowel Dis Ctr, Seoul, South Korea

[8] Icahn Sch Med Mt Sinai, Susan & Leonard Feinstein IBD Ctr, New York, NY USA

来源：

JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P179

引用

页码：I333 / I334

页数：2

共 50 条

[21] Efficacy and safety of upadacitinib induction therapy in patients with Moderately to Severely Active Ulcerative Colitis: Results from the phase 3 U-ACHIEVE study
Danese, S.
Vermeire, S.
Zhou, W.
Pangan, A.
Siffledeen, J.
Hebuterne, X.
Nakase, H.
Higgins, P.
Chen, M. H.
Sanchez-Gonzalez, Y.
Huang, B.
Xie, W.
Liu, J.
Weinreich, M.
Pannaccione, R.
JOURNAL OF CROHNS & COLITIS, 2021, 15 : S022 - S024
[22] Induction and Maintenance Treatment With Upadacitinib Improves Health-Related Quality of Life in Patients With Moderately to Severely Active Ulcerative Colitis: Phase 3 Study Results
Panes, Julian
Loftus, Edward, V
Higgins, Peter D. R.
Lindsay, James O.
Zhou, Wen
Yao, Xuan
Ilo, Dapo
Phillips, Charles
Tran, Jacinda
Sanchez Gonzalez, Yuri
Vermeire, Severine
INFLAMMATORY BOWEL DISEASES, 2023, : 1421 - 1430
[23] Efficacy and safety of upadacitinib as induction therapy in patients with Moderately to Severely Active Ulcerative Colitis: Results from phase 3 U-ACCOMPLISH study
Vermeire, S.
Danese, S.
Zhou, W.
Pangan, A.
Greenbloom, S.
D'Haens, G.
Panes, J.
Juillerat, P.
Lindsay, J. O.
Loftus, E. V., Jr.
Sandborn, W. J.
Reinisch, W.
Gonzalez, Y. Sanchez
Huang, B.
Xie, W.
Liu, J.
Weinreich, M. A.
Panaccione, R.
JOURNAL OF CROHNS & COLITIS, 2021, 15 : S021 - S022
[24] Efficacy and Safety of Upadacitinib Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Results From the Phase 3 U-ACHIEVE Study
Danese, Silvio
Vermeire, Severine
Zhou, Wen
Pangan, Aileen
Siffledeen, Jesse
Hebuterne, Xavier
Nakase, Hiroshi
Chen, Minhu
Higgins, Peter
Sanchez-Gonzalez, Yuri
Huang, Bidan
Xian, Wangang
Liu, Jianzhong
Weinreich, Michael
Panaccione, Remo
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S312 - S313
[25] Rapidity of Symptom Control with Upadacitinib Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Results From Two Randomized Phase 3 Studies
Loftus, Edward V.
Takeuchi, Ken
Gao, Xiang
Panaccione, Remo
Danese, Silvio
Ilo, Dapo
Finney-Hayward, Tricia
Phillips, Charles
Yao, Xuan
Vermeire, Severine
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S359 - S359
[26] Efficacy and Safety of Upadacitinib as Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Results From Phase 3 U-ACCOMPLISH Study
Vermeire, Severine
Danese, Silvio
Zhou, Wen
Pangan, Aileen
Greenbloom, Susan
D'Haens, Geert
Panes, Julian
Juillerat, Pascal
Lindsay, James
Loftus, Edward V.
Sandborn, William
Reinisch, Walter
Sanchez-Gonzalez, Yuri
Huang, Bidan
Xian, Wangang
Liu, Jianzhong
Weinreich, Michael
Panaccione, Remo
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S357 - S357
[27] Corticosteroid-Sparing Effect in Patients With Moderately to Severely Active Ulcerative Colitis Treated With Mirikizumab Maintenance Therapy
Laharie, David
Siegel, Corey A.
Samaan, Karen
Fischer, Deborah
Morris, Nathan
Redondo, Isabel
Dulai, Parambir S.
Jairath, Vipul
Gisbert, Javier P.
Matsuoka, Katsuyoshi
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S635 - S635
[28] CORTICOSTEROID-SPARING EFFECT IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS TREATED WITH MIRIKIZUMAB MAINTENANCE THERAPY
Laharie, D.
Siegel, C. A.
Samaan, K.
Fisher, D. A.
Morris, N.
Redondo, I.
Dulai, P. S.
Jairath, V.
Gisbert, J. P.
Matsuoka, K.
Orlando, A.
DIGESTIVE AND LIVER DISEASE, 2024, 56 : S163 - S164
[29] The effects of maintenance therapy with upadacitinib on abdominal pain, bowel urgency, and fatigue in patients with moderately to severely active Ulcerative Colitis: Phase 3 U-ACHIEVE maintenance results
Danese, S.
Tran, J.
D'Haens, G.
Rubin, D. T.
Aoyama, N.
Zhou, W.
James, B.
Yao, X.
Gonzalez, Y. Sanchez
Panaccione, R.
JOURNAL OF CROHNS & COLITIS, 2022, 16 : I008 - I009
[30] THE EFFECTS OF MAINTENANCE THERAPY WITH UPADACITINIB ON ABDOMINAL PAIN, BOWEL URGENCY, AND FATIGUE IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: PHASE 3 U--ACHIEVE MAINTENANCE RESULTS
Danese, Silvio
Tran, Jacinda
D'Haens, Geert R.
Rubin, David T.
Aoyama, Nobuo
Zhou, Wen
James, Barbara
Yao, Xuan
Gonzalez, Yuri Sanchez
Panaccione, Remo
GASTROENTEROLOGY, 2022, 162 (07) : S972 - S972

← 1 2 3 4 5 →